Skip to main content
Free Webinars

Transitioning to FDA’s New Premarket Submission Guidance

November 15, 2023
  •  
30
 minutes

CEO Erez Kaminski and former FDA expert Paul Jones review the 2023 Premarket Submission Guidance and how teams can better understand—and implement—new expectations for product development and submission.